Presentation THT Abstracts 2024 ImpellaÆ Use Improves Hemodynamics for Cardiogenic Shock from Ventricular Septal Defect (VSD) Presenter: Brent Medoff March 04, 2024
News Daily News Myocarditis After COVID Vaccination Is Rare, Resolves Quickly, Studies Confirm L.A. McKeown January 25, 2022
Presentation TCT 2020 TCT 523: Establishing Equilibrium: Transcaval Impella 5.0 Support to Enhance Clinical Stability in a Patient With Post-MI VSD and Lower Extremity PAD Prior to Delayed Surgical Repair Presenter: Eric Shin October 14, 2020
News Features Dire, Unusual STEMI Complications Blamed on COVID-19 Hospital Avoidance Shelley Wood April 29, 2020
Presentation TCT 2018 Case #1: Percutaneous Closure of Anything With Something - The Off-Label Use of Devices. Mitral Leak, Post-MI VSD, Ascending Aorta Pseudoaneurysm, LV Pseudoaneurysm Presenter: Joshua P. Loh, João A Silveira, Andres Jr N Baysa, Alexandre Schaan Quadros September 23, 2018
Presentation TCT 2018 Case #5: A Complication That Occurred When I Treated a Post-MI VSD Presenter: Henning Kelbæk, Ran Kornowski, Nirat Beohar, Miroslaw Ferenc, Mamas Mamas, James Nolan, Thomas M. Tu, Bernhard Witzenbichler September 22, 2018
News Industry News Occlutech obtains European CE Approval for its novel mVSD Device September 30, 2015